Clifford Chance advises premium skincare brand Forest Cabin on its IPO and listing in Hong Kong
30 December 2025
Clifford Chance advises premium skincare brand Forest Cabin on its IPO and listing in Hong Kong
The firm advised on 23 Hong Kong listings in 2025, reflecting robust IPO momentum
Global law firm Clifford Chance has advised Shanghai Forest Cabin Cosmetics Group Co., Ltd. (Forest Cabin) on its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange.
Forest Cabin is a premium skincare brand in China with a focus on the anti-aging and firming skincare market. Well-known for its camellia-based products, it is the top domestic brand within China's premium skincare market, by retail sales in 2024.
Chair of China Practice and partner Tim Wang co-led the transaction with partners Jean Thio and Virginia Lee and with support from Head of Capital Markets Lorna Lyu*, senior associate Yaping Li, associates Ruonan Tang, Cathy Qian, Xiao Tang, and Yao Han*, trainee solicitor Julie Luo, legal assistant Minnie Xu and legal analyst Iris Wang.
Tim said, "Forest Cabin's successful debut in Hong Kong reflects the sustained investor interest in Chinese consumer brands and a fitting close to a momentous year for our Greater China equity capital markets team. We are deeply grateful to our clients for trusting us with one of their most transformative milestones – accessing the public markets and connecting with global investors. From technology and industrials to consumer products, we have been proud to showcase the dynamic industries shaping the region's future.”
Hong Kong's capital markets experienced a strong resurgence in 2025, driven by investor demand for innovative, high growth industries – particularly from China.
Against this backdrop, Clifford Chance’s market-leading capital markets practice remained one of the most active international legal advisers on Hong Kong listings. The firm advised on 23 listings across sectors including AI, semiconductors, biotech, automotive and electric vehicles, and consumer products, raising over US$7.7 billion in total. Highlights include:
- Three large-cap A-to-H share listings, including one of the largest in 2025 by SANY Heavy Industry, which raised US$1.7 billion;
- First ever listing of a Thai company in Hong Kong (IFBH Limited);
- First ever dual listing in Hong Kong and Kazakhstan (Jiaxin International Resources);
- Two 18C (specialist technology) listings (Deepexi and CiDi);
- Two 18A (biotech) listings (Ab&B Bio-Tech and B&K Corp.)
* From Shanghai He Ping Law Firm. Clifford Chance LLP and Shanghai He Ping Law Firm have established a Joint Operation in the China (Shanghai) Pilot Free Trade Zone under the name Clifford Chance LLP and Shanghai He Ping Law Firm (FTZ) Joint Operation Office with the approval of the Shanghai Bureau of Justice.
高伟绅助力高端护肤品牌林清轩香港IPO及上市,以23单香港IPO圆满收官2025年
林清轩是中国高端护肤品牌,专注于抗衰及紧致类护肤品市场,凭借其山茶花系列产品而广为人知。2024年以零售额计,林清轩已成为中国高端护肤市场的本土第一品牌。
本交易由中国业务主席王彦峰与合伙人张珮真和李婉雯共同牵头,和平高伟绅联营办公室*团队为本交易提供服务。主要团队成员包括吕娜†、李亚平、唐若楠、钱超、唐潇、韩耀†、骆婷婷、徐姚瑶和王进颖。
王彦峰律师表示:"林清轩在香港成功上市,彰显了投资者对中国消费品牌的持续关注,也为我们大中华区股权资本市场团队意义非凡的一年画上圆满句号。我们衷心感谢客户在迈向公开市场、连接全球投资者这一关键阶段对我们的信任。从科技、工业到消费品,我们始终自豪地陪伴并助力这些充满活力、推动区域未来发展的行业。”
国际律师事务所高伟绅就上海林清轩化妆品集团股份有限公司(“林清轩”)首次公开发行及香港联合交易所主板上市,担任林清轩的国际法律顾问。2025年,在投资者对创新及高增长行业,尤其是中国企业的强劲投资需求推动下,香港资本市场实现了显著复苏。
在此背景下,高伟绅市场领先的资本市场团队继续稳居香港上市领域最活跃的国际律师事务所之列,为人工智能、半导体、生物科技、汽车与新能源车及消费品等多个行业的上市项目提供了法律服务。本年度高伟绅团队参与的香港IPO项目总融资额逾77亿美元,其中重大项目包括:
- 三宗大规模“A+H”上市项目,包括2025年融资规模最大的香港IPO之一,即,三一重工17亿美元的香港上市;
- 首宗泰国企业(IFBH Limited)香港上市;
- 首宗香港与哈萨克斯坦双重上市(佳鑫国际资源);
- 两宗18C章(特专科技公司)上市(滴普科技和希迪智驾);
- 两宗18A章(生物科技公司)上市(中慧生物和华芢生物)。
*和平高伟绅联营办公室是经上海市司法局批准由上海市和平律师事务所与高伟绅律师事务所在中国(上海)自由贸易试验区成立的联营办公室。
†任职于上海市和平律师事务所。